Summary & Overview
CPT 41112: Excision of Lesion, Anterior Two-Thirds of Tongue
CPT code 41112 denotes surgical excision of a lesion from the anterior two-thirds of the tongue. This procedure is clinically important for removal of benign or malignant lesions on the oral tongue, with implications for oncologic control, speech and swallowing function, and post-operative rehabilitation. Nationally, accurate coding of oral tongue excisions impacts claims processing, episode-of-care tracking, and quality measurement for head and neck surgical care.
Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Coverage policies and prior authorization practices for oral cavity procedures vary by payer, influencing site-of-service decisions and billing workflows.
Readers will find a concise overview of the clinical context and service setting for CPT code 41112, common payer considerations, and the types of benchmarks and policy updates typically examined when reviewing surgical head and neck procedure coding. The publication summarizes typical sites of service, payer coverage landscape, and operational billing considerations that affect claims submission and reimbursement. Data not available in the input will be noted where applicable.
Billing Code Overview
CPT code 41112 describes a surgical procedure in which the provider excises a lesion from the anterior two-thirds of the tongue. This represents a targeted excision of a localized tongue lesion and typically involves removal of mucosal and superficial muscular tissue from the oral tongue.
-
Service type: Surgical excision of lesion on the anterior tongue
-
Typical site of service: Ambulatory surgical center or hospital operating room, or outpatient surgical clinic depending on clinical complexity and anesthesia needs
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult presenting to an otolaryngology or oral surgery clinic with a suspicious or symptomatic lesion on the anterior two-thirds of the tongue (oral tongue). Common presentations include a persistent ulcerated lesion, exophytic mass, focal induration, or biopsy-proven dysplasia or squamous cell carcinoma requiring partial glossectomy. The clinical workflow includes history and head/neck examination, flexible or direct laryngoscopy as indicated, imaging (contrast CT or MRI of the neck for staging when cancer is suspected), and preoperative evaluation. In the operating room under general anesthesia, the surgeon performs an excision of the lesion with appropriate margins; frozen section pathology may be used intraoperatively to confirm margins. Hemostasis and layered closure are performed; depending on defect size, primary closure or reconstruction (local flap, free flap) may follow. Postoperative care includes airway monitoring, pain control, swallow assessment, pathology review, and referral for adjuvant therapy if malignancy is confirmed.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
25 | Significant, separately identifiable evaluation and management service by the same physician on the day of a procedure | Use when an E/M visit for a separately identifiable problem is provided same day as the excision |